ASTELLAS DOSES FIRST PATIENT IN PHASE 3 STUDY OF SETIDEGRASIB IN PREVIOUSLY TREATED KRAS G12D-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER

Reuters · 3d ago

Please log in to view news